Acute Inpatient Psychiatric Facilities was Acadia Healthcare Company’s largest product and service line in fiscal 2025, bringing in $1.83B of $3.31B (55%).
| Product and Service | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Acute Inpatient Psychiatric Facilities | $1.33B | $1.49B | $1.68B | $1.83B | ||||||
| Specialty Treatment Facilities | $564.67M | $614.22M | $592.02M | $567.20M | ||||||
| Health Care Facilities | — | — | — | — | ||||||
| Comprehensive Treatment Centers | $419.94M | $500.24M | $537.89M | $567.18M | ||||||
| Residential Treatment Centers | $295.03M | $325.03M | $345.79M | $348.07M | ||||||
| Adult Care Facilities | — | — | — | — | ||||||
| Education & Childrens Services | — | — | — | — | ||||||
| Outpatient Community-Based Services | — | — | — | — | ||||||
| Outpatient Community-Based Facilities | — | — | — | — | ||||||
| Other | — | — | — | — | ||||||
| Total | $2.61B | $2.93B | $3.15B | $3.31B |
Acadia Healthcare Company brought in $3.31B from its four product and service lines in fiscal 2025, the year ended December 31, 2025. That was up 5.0% from $3.15B in fiscal 2024. Acute Inpatient Psychiatric Facilities was the largest at $1.83B (55.3%), ahead of Specialty Treatment Facilities at $567.20M (17.1%) and Comprehensive Treatment Centers at $567.18M (17.1%). The remaining line, Residential Treatment Centers, brought in $348.07M.
Compared with fiscal 2024, Acute Inpatient Psychiatric Facilities grew fastest, up 9.1% to $1.83B, while Specialty Treatment Facilities fell the most, down 4.2% to $567.20M. From fiscal 2022 to 2025, combined revenue from these lines grew from $2.61B to $3.31B, a compound annual growth rate of 8.3%. Acute Inpatient Psychiatric Facilities' share of the total rose from 51.0% to 55.3%.
Medicaid was Acadia Healthcare Company’s largest revenue line in fiscal 2025, bringing in $1.91B of $3.31B (58%).
| Customer | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Medicaid | $1.32B | $1.58B | $1.78B | $1.91B | ||||||
| U.K. Public Funded Sources | — | — | — | — | ||||||
| Commercial | $788.90M | $820.70M | $820.83M | $813.79M | ||||||
| Medicare | $394.23M | $441.76M | $447.08M | $473.46M | ||||||
| Self-Pay | $76.05M | $67.58M | $60.10M | $64.82M | ||||||
| Other | $31.63M | $20.18M | $44.34M | $48.54M | ||||||
| Total | $2.61B | $2.93B | $3.15B | $3.31B |
Acadia Healthcare Company brought in $3.31B from its five revenue lines in fiscal 2025, the year ended December 31, 2025. That was up 5.0% from $3.15B in fiscal 2024. Medicaid was the largest at $1.91B (57.7%), ahead of Commercial at $813.79M (24.6%) and Medicare at $473.46M (14.3%). The other two revenue lines brought in $113.36M combined.
Compared with fiscal 2024, Medicaid grew fastest, up 7.3% to $1.91B, while Commercial fell the most, down 0.9% to $813.79M. From fiscal 2022 to 2025, combined revenue from these revenue lines grew from $2.61B to $3.31B, a compound annual growth rate of 8.3%. Medicaid's share of the total rose from 50.6% to 57.7%.
Combined Subsidiary Guarantors was Acadia Healthcare Company’s largest revenue line in fiscal 2017, bringing in $1.75B of $2.88B (61%).
| Consolidated Entities | FY 2015 | FY 2016 | FY 2017 |
|---|---|---|---|
| Combined Subsidiary Guarantors | $1.42B | $1.66B | $1.75B |
| Combined Non-Guarantors | $414.60M | $1.19B | $1.13B |
| Total | $1.83B | $2.85B | $2.88B |
Acadia Healthcare Company brought in $2.88B from its two revenue lines in fiscal 2017, the year ended December 31, 2017. That was up 0.9% from $2.85B in fiscal 2016. Combined Subsidiary Guarantors was the largest at $1.75B (60.7%), ahead of Combined Non-Guarantors at $1.13B (39.3%).
Compared with fiscal 2016, Combined Subsidiary Guarantors grew 5.0% to $1.75B, while Combined Non-Guarantors fell 5.0% to $1.13B. From fiscal 2015 to 2017, combined revenue from these revenue lines grew from $1.83B to $2.88B, a compound annual growth rate of 25.4%. Combined Subsidiary Guarantors' share of the total fell from 77.3% to 60.7%.
Acadia Healthcare Company (ACHC) reports its revenue by product and service, by customer and by consolidated entities. In fiscal 2025, Acute Inpatient Psychiatric Facilities was its largest product and service line, bringing in $1.83B (55.3% of the total), followed by Specialty Treatment Facilities at $567.20M (17.1%).
Acute Inpatient Psychiatric Facilities was Acadia Healthcare Company's largest product and service line in fiscal 2025, bringing in $1.83B, or 55.3% of the $3.31B total across its four product and service lines.
Medicaid was Acadia Healthcare Company's largest revenue line in fiscal 2025, bringing in $1.91B, or 57.7% of the $3.31B total across its five revenue lines.
Among Acadia Healthcare Company's product and service lines that make up at least 2% of revenue, Acute Inpatient Psychiatric Facilities grew fastest in fiscal 2025, up 9.1% from $1.68B to $1.83B.
Every figure comes from Acadia Healthcare Company's annual financial filings, as reported. Each line keeps the name Acadia Healthcare Company gives it, and years follow its fiscal calendar.
Acadia Healthcare Company's revenue by product and service goes back to fiscal 2016, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.